Found 329 matching trials
Efficacy and Safety of Immunotherapy With Allogeneic Dendritic Cells, DCP-001, in Patients With Acute Myeloid Leukaemia PHASE2 Phase II study to evaluate safety and efficacy of DCP-001 in patients with ...
Show More Location
Helsinki University Hospital
Learn More & Join Trial
Predictive Value of Minimal Residual Disease for Postoperative Recurrence and Adjuvant PD-1 Inhibitor in HCC NA Hepatocellular carcinoma (HCC) is a leading global cause of cancer-related ...
Show More Location
Division of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Optimization of Postoperative Adjuvant Therapy for Cervical Cancer Based on MRD(Minimal Residual Disease) PHASE2 This study is a prospective cohort clinical trial that aims to investigate ...
Show More Location
The Affiliated Suzhou Hospital of Nanjing Medical University
Learn More & Join Trial
PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS PHASE1 This is a first-in-human dose escalation/dose expansion study to evaluate t...
Show More Status
Active Not Recruiting
Location
H Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
Oral Arsenic Trioxide for NPM1-mutated AML PHASE2 A prospective open-label phase 2 study will be designed to assess the effic...
Show More Location
The University of Hong Kong
Learn More & Join Trial
Monitoring Minimal Residual Disease(MRD)in Pediatric B-acute Lymphoblastic Leukemia N/A This study aimed to investigate the performance of next-generation sequenci...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Pegasys in Patients With Chronic Myeloid Leukemia (CML) PHASE2 The goal of this clinical research study is to learn if adding pegylated in...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE) PHASE2 Multiple myeloma is characterized by a pattern of recurrent relapse and rem...
Show More Learn More & Join Trial
Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial NA The goal of this interventional clinical trial is to compare the efficacy o...
Show More Location
Multiple Locations
Learn More & Join Trial
To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT PHASE1 To observe the efficacy and safety of CD7-targeted chimeric antigen recepto...
Show More Location
Peking University People's Hospital
Learn More & Join Trial